Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

NCT01598168 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT01598168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01598168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2013
Completion date
July 31, 2015
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia